Enfuvirtidi

Enfuvirtidi is a antiretroviral medication used in the treatment of HIV infection. It belongs to a class of drugs known as fusion inhibitors. Enfuvirtidi works by preventing the HIV virus from entering human cells. Specifically, it binds to a protein on the surface of the virus that is crucial for its entry into CD4+ T cells, thereby blocking the fusion of the viral envelope with the cell membrane.

Enfuvirtidi is administered via subcutaneous injection, typically twice daily. It is generally used in combination with other antiretroviral drugs for the treatment of individuals with HIV-1 infection who have experienced treatment failure with other antiretroviral therapies. Its effectiveness is measured by its ability to reduce viral load and increase CD4+ cell counts.

The development of enfuvirtidi represented a significant advancement in HIV therapy, offering a new mechanism of action for patients with limited treatment options. However, like all medications, enfuvirtidi can cause side effects. Common side effects include injection site reactions such as pain, redness, and itching. Other potential side effects may include nausea, diarrhea, and fatigue. Regular monitoring by a healthcare professional is important to manage any adverse effects and assess treatment efficacy. Enfuvirtidi is not a cure for HIV but is an important tool in managing the infection and improving the quality of life for affected individuals.